| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P2093 | author name string | Jasim Anabrees | |
| Khalid AlFaleh | |||
| P2860 | cites work | Probiotics for prevention of necrotizing enterocolitis in preterm infants | Q24235681 |
| Probiotics for prevention of necrotizing enterocolitis in preterm infants | Q24242683 | ||
| Estimating the mean and variance from the median, range, and the size of a sample | Q24801782 | ||
| Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial | Q33440895 | ||
| Interactions mediating bacterial translocation in the immature intestine | Q33866203 | ||
| Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging | Q34051652 | ||
| Can bacterial interference prevent infection? | Q34090954 | ||
| New concepts in necrotizing enterocolitis | Q34228363 | ||
| Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome | Q34470700 | ||
| Treatment of necrotizing enterocolitis: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review | Q34481204 | ||
| Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial | Q34659239 | ||
| Neonatal necrotizing enterocolitis: an overview | Q35177882 | ||
| Probiotics for preterm infants? | Q35205685 | ||
| Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study | Q35220787 | ||
| Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial | Q35285379 | ||
| Effects of bifidobacterium breve supplementation on intestinal flora of low birth weight infants | Q80877314 | ||
| Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants | Q81224806 | ||
| Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis | Q84068152 | ||
| Probiotics reduce all-cause mortality and necrotizing enterocolitis: it is time to change practice | Q84077662 | ||
| Probiotics: are we ready for routine use? | Q84114515 | ||
| Treatment and prevention of necrotizing enterocolitis | Q35682601 | ||
| Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates | Q37733964 | ||
| A unifying hypothesis for pathogenesis and prevention of necrotizing enterocolitis | Q37817652 | ||
| Necrotizing enterocolitis in very low birth weight infants: a systemic review | Q38045310 | ||
| Surgical treatment of necrotizing enterocolitis and the short bowel syndrome. | Q40694568 | ||
| Nosocomial bacteremia caused by Bacillus species. | Q40781699 | ||
| Bacterial colonization of neonates admitted to an intensive care environment | Q40912248 | ||
| Necrotizing enterocolitis: the search for a unifying pathogenic theory leading to prevention | Q40978132 | ||
| Enteral feeding of premature infants with Lactobacillus GG | Q41817204 | ||
| Stool microflora in extremely low birthweight infants | Q41971187 | ||
| Effect of probiotics on enterocyte bacterial translocation in vitro | Q42505976 | ||
| Effects of feeding premature infants with Lactobacillus GG on gut fermentation | Q42584461 | ||
| Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. | Q43777978 | ||
| Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants | Q44078636 | ||
| Enteral feeding of premature infants with Saccharomyces boulardii | Q44633338 | ||
| Saccharomyces boulardii for prevention of necrotizing enterocolitis in preterm infants: a randomized, controlled study | Q46087545 | ||
| Comparison between killed and living probiotic usage versus placebo for the prevention of necrotizing enterocolitis and sepsis in neonates | Q46446325 | ||
| The politics of probiotics: probiotics, necrotizing enterocolitis and the ethics of neonatal research | Q46475461 | ||
| Effects of oral Lactobacillus GG on enteric microflora in low-birth-weight neonates | Q47172563 | ||
| Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network | Q47180140 | ||
| Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial | Q47187980 | ||
| Impact of necrotizing enterocolitis on length of stay and hospital charges in very low birth weight infants | Q47191580 | ||
| Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. | Q47212470 | ||
| Probiotics supplementation increases intestinal blood flow velocity in extremely low birth weight preterm infants | Q47319902 | ||
| Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network | Q47329159 | ||
| Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials | Q47332291 | ||
| Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates | Q47370646 | ||
| Probiotics-supplemented feeding in extremely low-birth-weight infants | Q47377896 | ||
| Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial | Q47395591 | ||
| Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection | Q47400735 | ||
| Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial | Q47407913 | ||
| Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: a randomized controlled trial | Q47440727 | ||
| Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. | Q50773084 | ||
| Lack of effect of Lactobacillus on gastrointestinal bacterial colonization in premature infants. | Q54420426 | ||
| Prophylactic Probiotics to Prevent Death and Nosocomial Infection in Preterm Infants | Q57570439 | ||
| The epidemiology of necrotizing enterocolitis infant mortality in the United States | Q64133392 | ||
| Comparative effects of ischemia, bacteria, and substrate on the pathogenesis of intestinal necrosis | Q69551236 | ||
| Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study | Q74593416 | ||
| The effect of a bifidobacter supplemented bovine milk on intestinal permeability of preterm infants | Q79577725 | ||
| P921 | main subject | probiotics | Q1816730 |
| necrotizing enterocolitis | Q10859678 | ||
| preterm infant | Q45051448 | ||
| P577 | publication date | 2014-04-10 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Probiotics for prevention of necrotizing enterocolitis in preterm infants |
| Q38402423 | A practical guide to the diagnosis, treatment, and prevention of neonatal infections |
| Q40081393 | A randomized synbiotic trial to prevent sepsis among infants in rural India |
| Q38427654 | A review of the systematic review process and its applicability for use in evaluating evidence for health claims on probiotic foods in the European Union |
| Q45945719 | Advances in paediatric gastroenterology. |
| Q57162277 | An enhanced Lactobacillus reuteri biofilm formulation that increases protection against experimental necrotizing enterocolitis |
| Q38750089 | Anti-inflammatory effects of Bifidobacterium longum subsp infantis secretions on fetal human enterocytes are mediated by TLR-4 receptors |
| Q91877779 | Application of abdominal sonography in diagnosis of infants with necrotizing enterocolitis |
| Q36054986 | Bacteremia in Preterm Infants Receiving Probiotics; Throbbing Headache Associated with Enoxaparin Use; DRESS Reaction Following Isoniazid Treatment; SIADH Associated with Glimepiride; Mania Associated with Bortezomib Administration |
| Q35949040 | Benefits of Bifidobacterium breve M-16V Supplementation in Preterm Neonates - A Retrospective Cohort Study |
| Q46714483 | Benefits of probiotics in preterm neonates in low-income and medium-income countries: a systematic review of randomised controlled trials |
| Q40886498 | Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial |
| Q42339835 | Bifidobacterium longum Subspecies infantis Bacteremia in 3 Extremely Preterm Infants Receiving Probiotics |
| Q26823017 | Bifidobacterium longum subspecies infantis: champion colonizer of the infant gut |
| Q91948457 | Clinical effect of probiotics in prevention or treatment of gastrointestinal disease in dogs: A systematic review |
| Q88229272 | Comparison of abdominal radiographs and sonography in prognostic prediction of infants with necrotizing enterocolitis |
| Q98564940 | Cost-effectiveness of probiotics for necrotizing enterocolitis prevention in very low birth weight infants |
| Q30369296 | Diagnostic value and disease evaluation significance of abdominal ultrasound inspection for neonatal necrotizing enterocolitis. |
| Q57520141 | Different strains of probiotics for preventing morbidity and mortality in preterm infants: a network meta-analysis |
| Q46202682 | Digestion of Human Milk Oligosaccharides by Bifidobacterium breve in the Premature Infant. |
| Q92723253 | Dysbiosis and Prematurity: Is There a Role for Probiotics? |
| Q90092315 | E-SCOPE: A Strategic Approach to Identify and Accelerate Implementation of Evidence-based Best Practices |
| Q33720577 | Early-Life Host-Microbiome Interphase: The Key Frontier for Immune Development |
| Q37729604 | Early Nutritional Interventions for Brain and Cognitive Development in Preterm Infants: A Review of the Literature |
| Q90462177 | Effect of Synthetic Vitamin A and Probiotics Supplementation for Prevention of Morbidity and Mortality during the Neonatal Period. A Systematic Review and Meta-Analysis of Studies from Low- and Middle-Income Countries |
| Q58114593 | Effect of fecal microbiota transplantation route of administration on gut colonization and host response in preterm pigs |
| Q90194529 | Effects of Electrospinning on the Viability of Ten Species of Lactic Acid Bacteria in Poly(Ethylene Oxide) Nanofibers |
| Q59798304 | Effects of Probiotic Supplementation on the Gut Microbiota and Antibiotic Resistome Development in Preterm Infants |
| Q47187585 | Effects of Probiotics on Necrotizing Enterocolitis, Sepsis, Intraventricular Hemorrhage, Mortality, Length of Hospital Stay, and Weight Gain in Very Preterm Infants: A Meta-Analysis |
| Q47919617 | Effects of probiotics on experimental necrotizing enterocolitis: a systematic review and meta-analysis |
| Q64235045 | Efficacy of Bifidobacterium Species in Prevention of Necrotizing Enterocolitis in Very-Low Birth Weight Infants. A Systematic Review |
| Q91937986 | Enteral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates |
| Q38704288 | Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants |
| Q64991137 | Feeding growth restricted premature neonates: a challenging perspective. |
| Q48055318 | Fifty years in neonatology |
| Q57478925 | Filling the Gaps: Current Research Directions for a Rational Use of Probiotics in Preterm Infants |
| Q36149730 | From Birth to "Immunohealth," Allergies and Enterocolitis |
| Q36816915 | Gut Microbiome: What We Do and Don't Know |
| Q39927380 | Gut bacteria dysbiosis and necrotising enterocolitis in very low birthweight infants: a prospective case-control study |
| Q35327333 | Gut microbiota of the very-low-birth-weight infant |
| Q49433372 | Immune-Mediated Mechanisms of Action of Probiotics and Synbiotics in Treating Pediatric Intestinal Diseases |
| Q57175340 | Immunomodulation to Prevent or Treat Neonatal Sepsis: Past, Present, and Future |
| Q59808133 | Impact of an In-House Pediatric Surgery Unit and Human Milk Centered Enteral Nutrition on Necrotizing Enterocolitis |
| Q38796288 | Impact of probiotics on necrotizing enterocolitis |
| Q92266563 | Implementation of a probiotic protocol to reduce rates of necrotizing enterocolitis |
| Q35636352 | Intestinal microbiota and its relationship with necrotizing enterocolitis. |
| Q54745237 | Is Promoting Gut Microbial Diversity in Neonatal Enterocolitis the NECst Step? |
| Q90478478 | Maternal probiotic supplementation for prevention of morbidity and mortality in preterm infants |
| Q38822502 | Microbial therapeutic interventions |
| Q99239633 | Microbiota Supplementation with Bifidobacterium and Lactobacillus Modifies the Preterm Infant Gut Microbiota and Metabolome: An Observational Study |
| Q38969590 | Multiple strains probiotics appear to be the most effective probiotics in the prevention of necrotizing enterocolitis and mortality: An updated meta-analysis |
| Q37193195 | Necrotising enterocolitis and mortality in preterm infants after introduction of probiotics: a quasi-experimental study |
| Q91644661 | Necrotizing Enterocolitis Pathophysiology: How Microbiome Data Alter Our Understanding |
| Q38876651 | Necrotizing enterocolitis and preterm infant gut bacteria |
| Q35047413 | Necrotizing enterocolitis in newborns: update in pathophysiology and newly emerging therapeutic strategies |
| Q26766235 | Necrotizing enterocolitis: controversies and challenges |
| Q57689125 | Neonatal interventions for preventing cerebral palsy: an overview of Cochrane Systematic Reviews |
| Q41475549 | Notes from the field: Fatal gastrointestinal mucormycosis in a premature infant associated with a contaminated dietary supplement--Connecticut, 2014. |
| Q89761262 | Nutrients and Microbiota in Lung Diseases of Prematurity: The Placenta-Gut-Lung Triangle |
| Q88318948 | Nutrition for Preterm Infants: 75 Years of History |
| Q90908555 | Nutritional interventions to reduce rates of infection, necrotizing enterocolitis and mortality in very preterm infants |
| Q40142108 | Nutritional strategies and gut microbiota composition as risk factors for necrotizing enterocolitis in very-preterm infants |
| Q64882513 | Poor Bifidobacterial Colonization Is Associated with Late Provision of Colostrum and Improved with Probiotic Supplementation in Low Birth Weight Infants. |
| Q90598922 | Potential use of multi-strain synbiotics for improving postnatal head circumference |
| Q30235610 | Prevention and treatment of neonatal nosocomial infections. |
| Q37347035 | Prevention of necrotizing enterocolitis with probiotics: a systematic review and meta-analysis |
| Q36863473 | Probiotic Administration in Infants With Gastroschisis: A Pilot Randomized Placebo-Controlled Trial. |
| Q47128430 | Probiotic Supplementation in Preterm Infants Does Not Affect the Risk of Bronchopulmonary Dysplasia: A Meta-Analysis of Randomized Controlled Trials. |
| Q90136154 | Probiotic protocols used in neonatal intensive care units in the USA and Canada |
| Q30248234 | Probiotic supplementation in children with cystic fibrosis-a systematic review |
| Q26800020 | Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases |
| Q42366144 | Probiotics and Innate and Adaptive Immune Responses in Premature Infants |
| Q26739951 | Probiotics and Time to Achieve Full Enteral Feeding in Human Milk-Fed and Formula-Fed Preterm Infants: Systematic Review and Meta-Analysis |
| Q37113302 | Probiotics and mastitis: evidence-based marketing? |
| Q38590665 | Probiotics and necrotizing enterocolitis |
| Q38268271 | Probiotics and pregnancy. |
| Q88450335 | Probiotics and the development of very low birthweight infants: follow-up study of a randomised trial |
| Q26764805 | Probiotics for Preventing Late-Onset Sepsis in Preterm Neonates: A PRISMA-Compliant Systematic Review and Meta-Analysis of Randomized Controlled Trials |
| Q92135542 | Probiotics for Prevention of Severe Necrotizing Enterocolitis: Experience of New Zealand Neonatal Intensive Care Units |
| Q91259702 | Probiotics for preterm infants: A National Retrospective Cohort Study |
| Q28081613 | Probiotics for prevention of necrotizing enterocolitis in preterm infants: systematic review and meta-analysis |
| Q26471609 | Probiotics for the post-operative management of term neonates after gastrointestinal surgery |
| Q88323935 | Probiotics for the prevention of surgical necrotising enterocolitis: systematic review and meta-analysis |
| Q94336613 | Probiotics for the prevention or treatment of hyperbilirubinaemia in late preterm and term neonates |
| Q26747748 | Probiotics in critically ill children |
| Q92876444 | Probiotics in the next-generation sequencing era |
| Q92086037 | Probiotics supplementation and length of hospital stay in neonates with gastrointestinal surgery |
| Q58663183 | Probiotics to prevent early-life infection |
| Q95725368 | Probiotics, prematurity and neurodevelopment: follow-up of a randomised trial |
| Q36058834 | Protective Effect of Dual-Strain Probiotics in Preterm Infants: A Multi-Center Time Series Analysis. |
| Q57044288 | Protocol for the Lactoferrin Infant Feeding Trial (LIFT): a randomised trial of adding lactoferrin to the feeds of very-low birthweight babies prior to hospital discharge |
| Q33766262 | Reducing Viability Bias in Analysis of Gut Microbiota in Preterm Infants at Risk of NEC and Sepsis |
| Q50859271 | Reducing unnecessary antibiotic exposure in preterm neonates: an achievable goal. |
| Q50272428 | Reduction in necrotizing enterocolitis and improved outcomes in preterm infants following routine supplementation with Lactobacillus GG in combination with bovine lactoferrin |
| Q26768244 | Respiratory Microbiome of New-Born Infants |
| Q33564438 | Risk factors for necrotizing enterocolitis in neonates: a systematic review of prognostic studies |
| Q47648511 | Role of priority effects in the early-life assembly of the gut microbiota. |
| Q35844199 | Role of probiotics VSL#3 in prevention of suspected sepsis in low birthweight infants in India: a randomised controlled trial |
| Q55383691 | Role of the gut microbiota in nutrition and health. |
| Q36599103 | Short- and Long-Term Outcomes for Extremely Preterm Infants. |
| Q41004993 | Should pediatric infectious diseases physicians be proponents of probiotics? |
| Q38867454 | Standardized feeding regimen for reducing necrotizing enterocolitis in preterm infants: an updated systematic review. |
| Q38943477 | Survey and evidence based review of probiotics used in very low birth weight preterm infants within the United States. |
| Q89548454 | Synbiotic use for the prevention of sepsis and necrotizing enterocolitis in very low birth weight neonates: a randomized controlled trial |
| Q36235952 | Temporal bacterial and metabolic development of the preterm gut reveals specific signatures in health and disease |
| Q36280217 | The "Golden Age" of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants |
| Q35947109 | The Developing Microbiome of the Preterm Infant |
| Q46265536 | The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota. |
| Q40075191 | The Intestinal Microbiome in Infectious Diseases: The Clinical Relevance of a Rapidly Emerging Field. |
| Q33817825 | The Microbiome of Infants Recruited to a Randomised Placebo-controlled Probiotic Trial (PiPS Trial) |
| Q39287686 | The Microbiota of the Extremely Preterm Infant |
| Q46280449 | The Neonatal Microbiome: Implications for Neonatal Intensive Care Unit Nurses |
| Q57174271 | The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation |
| Q37677906 | The Role of Mucosal Immunity in the Pathogenesis of Necrotizing Enterocolitis |
| Q28075770 | The Significance of the Enteric Microbiome on the Development of Childhood Disease: A Review of Prebiotic and Probiotic Therapies in Disorders of Childhood |
| Q92628693 | The clinical management and outcomes of extremely preterm infants in Japan: past, present, and future |
| Q35044607 | The composition of the gut microbiota throughout life, with an emphasis on early life. |
| Q28080685 | The human neonatal gut microbiome: a brief review |
| Q26860976 | The impact of the milk glycobiome on the neonate gut microbiota |
| Q93332321 | The microbiome and ophthalmic disease |
| Q35318848 | The role of intestinal epithelial barrier function in the development of NEC. |
| Q41500147 | The skin microbiome: impact of modern environments on skin ecology, barrier integrity, and systemic immune programming. |
| Q36302412 | The symbiotic bacterial surface factor polysaccharide A on Bacteroides fragilis inhibits IL-1β-induced inflammation in human fetal enterocytes via toll receptors 2 and 4 |
| Q39391152 | Using probiotics in clinical practice: Where are we now? A review of existing meta-analyses. |
| Q54919986 | Vitamins and functional nutrients for extremely low birth weight infants. |
| Q26747090 | hPSC-derived lung and intestinal organoids as models of human fetal tissue |
Search more.